DNA fragments that activate A2A adenosine receptors, triggering the skin's own collagen synthesis and wound-healing response. A clinical staple in Korea and Europe for years, now arriving in retail serums. Adore Beauty Australia's 2026 ingredient guide lists PDRN among the next big mainstream actives. Clark's Botanicals' May 2026 launch uses a vegan rice + barley-derived PDRN complex.
Benefits
stimulates collagen and tissue repair
supports post-laser and post-procedure recovery
improves atrophic acne scars and elasticity
Example uses
regenerative serums
post-procedure ampoules
longevity treatments
Mechanism of action
Low-molecular-weight (50–1500 kDa) DNA fragments that engage adenosine A2A receptors on fibroblasts, keratinocytes, and inflammatory cells. A2A activation triggers downstream pro-angiogenic (VEGF), pro-collagen (TGF-β1), and anti-inflammatory (suppressed TNF-α, IL-6) signalling cascades — the molecular basis for the documented acceleration of wound healing, post-laser recovery, and atrophic-scar remodelling. The DNA fragment also contributes nucleotide-salvage substrates supporting accelerated cellular proliferation. Mesotherapy and intradermal PDRN protocols (Korea, Italy) have a much deeper clinical literature than topical cosmetic use.
Clinical evidence · Moderate
Strong clinical evidence for injected/mesotherapy PDRN in atrophic scarring, post-laser recovery, and tissue regeneration; topical cosmetic-cream evidence is much thinner, with the penetration-of-DNA-through-stratum-corneum question still open.
Effective concentration range
0.5–3% in topical serums (vs. mesotherapy concentrations multiples higher)
Formulation notes
Frequently combined with plant-derived exosomes and peptides for compounded longevity claims.
Watchouts
Traditionally extracted from salmon sperm or trout gonads — confirm vegan biotech sourcing for clean positioning.
Source is the chronic transparency issue — historically PDRN is salmon-sperm or trout-gonad derived (the marine origin still dominates supply), creating veganism, kosher/halal, and sustainability questions. 'Plant-derived' or biotech-fermented alternatives exist but are not always identical molecules. The topical-vs-injection efficacy gap is widely papered over in marketing that borrows credibility from mesotherapy literature.
Market positioning
The 2024–2026 crossover from Korean dermatology clinics to retail serums — Mary & May, Beauty of Joseon, and a wave of biotech-clean US launches positioning it as the next post-snail K-beauty active. Real value at injectable doses is well-established; topical efficacy is genuinely uncertain and brand claims should be read carefully.
Comedogenicity
0 / 5
Sensitisation risk
Low
INCI & aliases
Polydeoxyribonucleotide / Sodium DNA
Clean beauty perception
Emerging — clinically serious; ethics resolved only when sourcing is vegan biotech.